Archives: Resources
Scientific and regulatory support for biotech trials
Explore how early scientific engagement enables biotechs to optimize trial design, endpoint strategy, data quality and regulatory planning.
Five considerations to differentiate your oncology drug
Explore how patient-reported outcomes and eCOA strategy capture quality-of-life data that differentiates oncology treatments.
Cognitive and wearable sensor assessments in Alzheimer’s
Explore how cognitive assessments and wearable sensor-based gait measures are being studied in Alzheimer’s disease and mild cognitive impairment.
Comprehensive services for neuroscience trials
Explore imaging, cardiac safety, eCOA and adjudication services that support high-quality endpoint data in neuroscience clinical trials.
GLP-1 agonist development: endpoint strategies to help differentiate your drug webinar replay
Discover endpoint strategies for GLP-1 trials, including FDA guidance, clinical adjudication and imaging approaches for drug differentiation.
Clario delivers study setup in 10 weeks for a global chronic weight management study
Discover how rapid eCOA setup supported study timelines, site readiness and enrollment in a global Phase III chronic weight management trial.
AI applications in neuroscience drug development
Discover how AI-enabled tools support neuroscience trials through vocal biomarkers, rater training and imaging analysis.
FDA guidance on weight management drug trials
Explore key FDA guidance takeaways for weight management trials, including efficacy endpoints, COAs and patient-centered differentiation.
Empowering Successful Transitions to Mixed FSP/FSO Model Outsourcing Partnerships
Learn how mixed FSP/FSO outsourcing models improve agility, scalability and operational efficiency in clinical development partnerships.